Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Reexamination Certificate
2006-08-22
2006-08-22
Dodson, Shelley A. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
C424S449000
Reexamination Certificate
active
07094422
ABSTRACT:
The present invention provides a topical drug delivery system which comprises: a therapeutically effective amount of an antifungal agent; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and a volatile liquid. The invention also provides a method for administering at least one systemic acting antifungal agent to an animal which comprises applying an effective amount of the antifungal agent in the form of the drug delivery system of the present invention.
REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3742951 (1973-07-01), Zaffaroni
patent: 3814097 (1974-06-01), Ganderton et al.
patent: 3921636 (1975-11-01), Zaffaroni
patent: 3989816 (1976-11-01), Rajadhyaksha
patent: 3993072 (1976-11-01), Zaffaroni
patent: 3993073 (1976-11-01), Zaffaroni
patent: 3996934 (1976-12-01), Zaffaroni
patent: 4031894 (1977-06-01), Urquhart et al.
patent: 4060084 (1977-11-01), Chandrasekaran et al.
patent: 4069307 (1978-01-01), Higuchi et al.
patent: 4077407 (1978-03-01), Theeuwes et al.
patent: 4201211 (1980-05-01), Chandrasekaran et al.
patent: 4230105 (1980-10-01), Harwood
patent: 4292299 (1981-09-01), Suzuki et al.
patent: 4292303 (1981-09-01), Keith et al.
patent: 4299826 (1981-11-01), Luedders
patent: 4310511 (1982-01-01), Holick
patent: 4440777 (1984-04-01), Zupan
patent: 4557934 (1985-12-01), Cooper
patent: 4663157 (1987-05-01), Brock
patent: 4699779 (1987-10-01), Palinczar
patent: 4704406 (1987-11-01), Stanislaus et al.
patent: 4820724 (1989-04-01), Nimni
patent: 4820742 (1989-04-01), Alexander et al.
patent: 4938951 (1990-07-01), Leung et al.
patent: 4941880 (1990-07-01), Burns
patent: 4946671 (1990-08-01), Bissett et al.
patent: 4954487 (1990-09-01), Cooper et al.
patent: 5023085 (1991-06-01), Francoeur et al.
patent: 5034386 (1991-07-01), Peck et al.
patent: 5036100 (1991-07-01), Deboeck et al.
patent: 5082656 (1992-01-01), Hui et al.
patent: 5082866 (1992-01-01), Wong et al.
patent: 5122519 (1992-06-01), Ritter
patent: 5256647 (1993-10-01), Minaskanian et al.
patent: 5323769 (1994-06-01), Bommannan et al.
patent: 5449519 (1995-09-01), Wolf et al.
patent: 5474783 (1995-12-01), Miranda et al.
patent: 5487898 (1996-01-01), Lu et al.
patent: 5573754 (1996-11-01), Kulkarni et al.
patent: 5679374 (1997-10-01), Franchon et al.
patent: 5804168 (1998-09-01), Murad
patent: 6299600 (2001-10-01), Masaoka et al.
patent: 6299900 (2001-10-01), Reed et al.
patent: 30258/89 (1989-09-01), None
patent: 49984/1990 (1989-09-01), None
patent: 91413/91 (1992-06-01), None
patent: 43 34 553 (1995-04-01), None
patent: 189 861 (1986-08-01), None
patent: 0 552 405 (1993-07-01), None
patent: 0 608 322 (1998-07-01), None
patent: 61-268631 (1986-11-01), None
patent: WO 92/19271 (1992-11-01), None
patent: WO 96/30000 (1996-10-01), None
R.J. Feldmann et al., “Percutaneous Penetration of 14C Hydrocortisone in Man”, Arch Derm, vol. 94:649-651, (1966).
M.F. Coldman et al., “Enhancement of Percutaneous Absorption by the Use of Volatile: Nonvolatile Systems and Vehicles”, Journal of Pharmaceutical Sciences, vol. 58(9): 1098-1102, (1969).
P.P. Bhatt et al., “Finite Dose Transport of Drugs in Liquid Formulations Through Stratum Corneum: Analytical Solution to a Diffusion Model”, International Journal of Pharmaceutics, Elsevier Science Publishers B.V. vol. 50:197-203, (1989).
Bucks et al., Percutaneous Absorption of Hydroquinone in Humans: Effect of 1-Dodecylazacloheptan-2-One (Azone) and the 2 Ethylhexyl Ester of 4-(Dimethylamino) Benzoic Acid (Escalol 507), Journal of Toxicology and Evironmental Health, 24:279-289 (1988).
Physicians' Desk Reference (49 Ed.) 1995, pp. 1151-1152, Medical Economics Company, Inc. Montvale N.J.
Khabir Ahmed “US Physicians and WHO plead for aid to Afghanistan”, The Lancet, vol. 357, Jun. 2001, pp. 1769.
William M. Chambers et al., “Terbinafine-Induced hepatic dysfunction”, European Journal of Gastroenterology & Hepatology 2001, vol. 13, No. 9, pp. 1115-1118.
D.T. Roberts, “Onychomycosis: current treatment and future challenges”, British Journal of Dermatology, 1999, 141 (Suppl. 56):1-4.
A. Tosti et al., “Relapses of Onychomycosis after Succesful Treatment with Systemic Antifungals: A Three Year Follow Up”, Dermatology 1998: 197: 162-166.
Daniele Debruyne et al., “Pharmacokinetics of Antifungal Agents in Onychomycoses”, Clin. Pharmacokinet 2001: 40:(6): 441-472.
Claus Seebacher et al., “A Multicenter, Open-Label Study of the Efficacy and Safety of Ciciopirox Nail Lacquer Solution 8% for the Treatment of Onychomycosis in Patients with Diabetes”, Efficacy and Safety of Ciclopirox, vol. 68, Aug. 2001, pp. 17-22.
Roderick James Hay et al., “Risk/benefit ratio of modern antifungal therapy: Focus on hepatic reactions”, Journal of the American Academy of Dermatology, Jul. 1993, pp. S50-S54.
D.T. Roberts, “Oral Terbinafine (Lamisil®) in the Treatment of Fungal Infections of the Skin and Nails”, Dermatology 1997, 194 (supp 1):37-39.
Harvey Lemont et al., “Terbinafine-Associated Taste Disturbance with Normal Taste Threshold Scores”, Journal of the American Podiatric Medical Association, pp. 540-541.
M. Zaug et al., “Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview)”, Clinical and Experimental Dermatology 1992, 17 (Suppl. 1): 61-70.
R.J. Hay et al., “Tioconazole nail solution—an open study of its efficacy in onychomycosis”, Clinical and Experimental Dermatology (1985) 10, 111-115.
Barrie C. Finnin et al., “Transdermal Penetration Enhancers: Applications, Limitations, and Potential”, Journal Pharmaceutical Sciences, vol. 88, No. 10, Oct. 1999, pp. 955-958.
Aditya K. Gupta et al., “Ciclopirox nail lacquer solution 8% in the 21stcentury” J. Am. Acad Dermatol, Oct. 2000, pp. S96-S102.
Chew Nora Yat Knork
Finnin Barrie Charles
Morgan Timothy Matthias
Reed Barry Leonard
Acrux DDS PTY Ltd.
Dodson Shelley A.
Foley & Lardner LLP
George Konata M.
LandOfFree
Topical delivery of antifungal agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical delivery of antifungal agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical delivery of antifungal agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649764